Select status:
Sort by:
Filter by last updated date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and August 2019

Filter by type
Showing 1 to 10 of 444
Title Reference number Published Last updated
Risankizumab for treating moderate to severe plaque psoriasis Reference number:TA596 TA00596 Published:August 2019 20190801 Last updated:August 2019 20190821
Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer Reference number:TA593 TA00593 Published:August 2019 20190801 Last updated:August 2019 20190814
Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal) Reference number:TA594 TA00594 Published:August 2019 20190801 Last updated:August 2019 20190814
Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer Reference number:TA595 TA00595 Published:August 2019 20190801 Last updated:August 2019 20190814
Cemiplimab for treating metastatic or locally advanced cutaneous squamous cell carcinoma Reference number:TA592 TA00592 Published:August 2019 20190801 Last updated:August 2019 20190807
Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis Reference number:TA590 TA00590 Published:July 2019 20190701 Last updated:July 2019 20190731
Letermovir for preventing cytomegalovirus disease after a stem cell transplant Reference number:TA591 TA00591 Published:July 2019 20190701 Last updated:July 2019 20190731
Nusinersen for treating spinal muscular atrophy Reference number:TA588 TA00588 Published:July 2019 20190701 Last updated:July 2019 20190724
Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activity Reference number:TA589 TA00589 Published:July 2019 20190701 Last updated:July 2019 20190724
Bisphosphonates for treating osteoporosis Reference number:TA464 TA00464 Published:August 2017 20170801 Last updated:July 2019 20190708